| Darrella Star Montoya, | |
|
2055 E 99th Ave, Thornton, CO 80229-2480 | |
| (720) 737-1194 | |
| Not Available |
| Full Name | Darrella Star Montoya |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist |
| Location | 2055 E 99th Ave, Thornton, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922508894 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | 0200762 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Darrella Star Montoya, 2055 E 99th Ave, Thornton, CO 80229-2480 Ph: (720) 737-1194 | Darrella Star Montoya, 2055 E 99th Ave, Thornton, CO 80229-2480 Ph: (720) 737-1194 |
News Archive
pSivida Corp., a specialty pharmaceutical company that is a leader in the development of sustained release ophthalmic drug treatments, today announced that its licensee Alimera Sciences, Inc. reported the submission of its response to the second Complete Response Letter from the U.S. Food and Drug Administration with respect to ILUVIEN for chronic diabetic macular edema.
A somatic mutation in the ATRX gene has recently been shown as a potential molecular marker for aggressive brain tumors, such as gliomas, neuroblastomas and pancreatic neuroendocrine tumors. Now, for the first time, researchers at Penn's Abramson Cancer Center have found that the same mutated gene may serve as a much-needed biomarker for the pheochromocytomas and paragangliomas (PCC/PGL) that become malignant.
GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.
Heparin plays a key role in allergic and inflammatory reactions driven by mast cells, scientists from Karolinska Institutet in Sweden shows in an international collaboration involving colleagues from Germany and Switzerland. The study is published in the recent issue of Immunity, and sheds some new light on the biological function of heparin.
Taiho Pharmaceutical Co., Ltd.(Japan) and Servier (France) announced on June 15 that they have entered into an exclusive license agreement on June 12, 2015 for the development and commercialization of TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride) in Europe and other countries.
› Verified 6 days ago
Joshua Van Williams, AG-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 13343 Cherry Cir, Thornton, CO 80241 Phone: 318-547-3489 | |
Mrs. Mary Irene Bobye, APRN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 8931 Huron St, Thornton, CO 80260 Phone: 303-853-3654 Fax: 303-853-3656 |